Johnson Matthey (Oxymorphone Patent) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Johnson Matthey (Oxymorphone Patent) General Information

Description

A pharmaceutical ingredient. The patent 7,851,482 B2 for oxymorphone hydrochloride in United States, utilized as a key ingredient for the formulation of OPANA drugs which is a semi-synthetic opioid analgesic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Commercial Services
Primary Office
  • 25 Farringdon Street
  • 5th Floor
  • London EC4A 4AB
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Johnson Matthey (Oxymorphone Patent) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Johnson Matthey (Oxymorphone Patent)‘s full profile, request access.

Request a free trial

Johnson Matthey (Oxymorphone Patent) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Johnson Matthey (Oxymorphone Patent)‘s full profile, request access.

Request a free trial